Position in NVS
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$3,291
+$84 QoQ
Shares Held
21
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,575
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kozak & Associates, Inc. holds $2,325,731 across 14 Drug Manufacturers - General names. NVS ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,766 | $1,199,316 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,000 | $379,020 | |
| 3 | JNJ |
Johnson & Johnson
|
1,219 | $309,589 | |
| 4 | AMGN |
Amgen Inc
|
389 | $140,864 | |
| 5 | MRK |
Merck & Co., Inc.
|
951 | $122,203 | |
| 6 | LLY |
ELI LILLY & Co
|
50 | $59,971 | |
| 7 | AZN |
Astrazeneca PLC
|
253 | $47,973 | |
| 8 | NVO |
Novo Nordisk A S
|
593 | $28,428 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,291 | 21 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $3,207 | 21 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $2,895 | 21 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $2,693 | 21 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $121,010 | 1,000 | Shares | Sole | 2025-07-10 | |
| No filing history on record for this holder in this stock. | ||||||